News / Health

    Malaria Vaccine Offers Hope

    This undated photo supplied by WGBH/Nova shows a mosquito at work.
    This undated photo supplied by WGBH/Nova shows a mosquito at work.

    Related Articles

    Study: Pregnant Women Not Gaining Access to Malaria Prevention

    Malaria infections, primarily in sub-Saharan Africa, responsible for deaths of some 200,000 newborns and 10,000 new mothers each year

    Audio Warmer Temps Trigger More Disease

    Scientists say climate change creating favorable environment for germs, pests
    VOA News
    An experimental malaria vaccine appears to offer protection against infection in healthy adults, according to U.S. researchers. The researchers also say early results indicate the vaccine is safe and “generated an immune response” in the group of volunteers tested.

    The vaccine, known as PfSPZ, is composed of live but weakened sporozoites of the species Plasmodium falciparum, the most deadly of the malaria-causing parasites.

    Malaria is transmitted to humans by the bite of an infected mosquito. After the bite occurs, infectious malaria parasites in the immature, sporozoite stage of their life cycle, first travel to the liver, where they multiply, and then spread through the bloodstream.

    “In this trial, we showed in principle that sporozoites can be developed into a malaria vaccine that confers high levels of protection and is made using the good manufacturing practices that are required for vaccine licensure,” said Dr. Robert A. Seder, chief of the Cellular Immunology Section of the NIAID Vaccine Research Center and principal investigator of the trial.

    One potential drawback to the vaccine is that it appeared most effective when administered intravenously because lower doses given under the skin did not yield similar results.

    “Despite this challenge, these trial results are a promising first step in generating high-level protection against malaria, and they allow for future studies to optimize the dose, schedule and delivery route of the candidate vaccine,” said Seder.

    Fifty-seven adults between 18 and 45 years old took part in Phase One of the trial. Forty received the vaccine and 17 did not. Some of those who received the vaccine were given increasing doses. After seven days of monitoring, “no severe adverse effects associated with the vaccine occurred, and no malaria infections related to vaccination were observed.”

    Furthermore, those who received the most vaccine generated more antibodies against malaria, researchers said.

    Three weeks after the last dosage, participants -- both those who received the vaccine and the control group -- were exposed to bites from five mosquitoes carrying the P. falciparum strain from which the PfSPZ Vaccine was derived.

    The researchers found that the higher dosages of PfSPZ Vaccine were associated with protection against malaria infection. Only three of the 15 participants who received higher doses of the vaccine became infected, compared to 16 of 17 participants in the lower dose group who became infected. Among the 12 participants who received no vaccine, 11 participants became infected, researchers said.

    Researchers say they plan several follow-up studies to test dosage schedules and whether larger doses delivered under the skin can offer the same immune response.

    “The global burden of malaria is extraordinary and unacceptable,” said Dr. Anthony Fauci, the NIAID director. “Scientists and health care providers have made significant gains in characterizing, treating and preventing malaria; however, a vaccine has remained an elusive goal. We are encouraged by this important step forward.”

    The vaccine was developed by scientists at Sanaria Inc. The clinical evaluation was conducted by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and their collaborators at the Walter Reed Army Institute of Research and the Naval Medical Research Center.

    The results of the study were published in the August 8 issue of Science.

    You May Like

    Rubio Looks to Surge in New Hampshire

    Republican presidential candidate has moved into second place in several recent surveys and appears to be gaining ground on longtime frontrunner Donald Trump

    UN Calls for Global Ban on Female Genital Mutilation

    Recent UNICEF report finds at least 200 million girls and women alive today have undergone female genital mutilation in 30 countries

    UN Pilots New Peace Approach in CAR

    Approach launched in northern town of Kaga Bandoro, where former combatants of mainly Muslim Seleka armed group and Christian and animist anti-Balaka movement are being paid to do community work

    This forum has been closed.
    Comment Sorting
    Comments
         
    by: Toogee from: South Lake Tahoe
    August 11, 2013 9:31 PM
    This pic shown is that of an Aedes aegypti, which vectors a few nasty pathogens like dengue fever, chikungunya and yellow fever, but isn't a primary vector of malaria, is it?

    by: kooni from: missipi
    August 11, 2013 6:50 PM
    they weren't actually bitten by the mosquito you idiot, there blood was tested with the malaria to see if the white cells respond to it.

    by: Cranksy from: USA
    August 09, 2013 1:31 PM
    "Three weeks after the last dosage, participants -- both those who received the vaccine and the control group -- were exposed to bites from five mosquitoes carrying the P. falciparum strain from which the PfSPZ Vaccine was derived." I read the linked material that stated "[t]his controlled human malaria infection procedure — a standard process in malaria vaccine trials...." Isn't this type of exposure considered unethical? Volunteers or not these people didn't simply remain or return to the places where they live their lives to be naturally exposed to P. falciparum "the most deadly form of the malaria-causing parasites."

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    German Artists to Memorialize Refugees With Life Jacket Exhibiti
    X
    Hamada Elsaram
    February 05, 2016 4:30 PM
    Sold in every kind of shop in some Turkish port towns, life jackets have become a symbol of the refugee crisis that brought a million people to Europe in 2015.  On the shores of Lesbos, Greece, German artists collect discarded life jackets as they prepare an art installation they plan to display in Germany.  For VOA, Hamada Elrasam has this report from Lesbos, Greece.
    Video

    Video German Artists to Memorialize Refugees With Life Jacket Exhibit

    Sold in every kind of shop in some Turkish port towns, life jackets have become a symbol of the refugee crisis that brought a million people to Europe in 2015.  On the shores of Lesbos, Greece, German artists collect discarded life jackets as they prepare an art installation they plan to display in Germany.  For VOA, Hamada Elrasam has this report from Lesbos, Greece.
    Video

    Video E-readers Help Ease Africa's Book Shortage

    Millions of people in Africa can't read, and there's a chronic shortage of books. A non-profit organization called Worldreader is trying to help change all that one e-reader at a time. VOA’s Deborah Block tells us about a girls' school in Nairobi, Kenya where Worldreader is making a difference.
    Video

    Video Genius Lets World Share Its Knowledge

    Inspired by crowdsourcing companies like Wikipedia, Genius allows anyone to edit anything on the web, using its web annotation tool
    Video

    Video Former Drug CEO Martin Shkreli Angers US Lawmakers

    A former U.S. pharmaceutical business executive has angered lawmakers by refusing to explain why he raised the price of a life-saving pill by 5,000 percent. Martin Shkreli was removed from a congressional hearing on Thursday after citing his Fifth Amendment right to stay silent. Zlatica Hoke has more.
    Video

    Video Super Bowl TV Commercials are Super Business for Advertisers

    The Super Bowl, the championship clash between the two top teams in American Football, is the most-watched sporting event of the year, and advertisers are lining up and paying big bucks to get their commercials on the air. In fact, the TV commercials during the Super Bowl have become one of the most anticipated and popular features of the event. VOA's Brian Allen has a sneak peek of what you can expect to see when the big game goes to commercial break, and the real entertainment begins.
    Video

    Video In Philippines, Mixed Feelings About Greater US Military Presence

    In the Philippines, some who will be directly affected by a recent Supreme Court decision clearing the way for more United States troop visits are having mixed reactions.  The increased rotations come at a time when the Philippines is trying to build up its military in the face of growing maritime assertiveness from China.  From Bahile, Palawan on the coast of the South China Sea, Simone Orendain has this story.
    Video

    Video Microcephaly's Connection to Zika: Guilty Until Proven Innocent

    The Zika virus rarely causes problems for the people who get it, but it seems to be having a devastating impact on babies whose mothers are infected with Zika. VOA's Carol Pearson has more.
    Video

    Video Solar Innovation Provides Cheap, Clean Energy to Kenya Residents

    In Kenya, a company called M-Kopa Solar is providing clean energy to more than 300,000 homes across East Africa by allowing customers to "pay-as-you-go" via their cell phones. As Lenny Ruvaga reports from Kangemi, customers pay a small deposit for a solar unit and then pay less than a dollar a day to get clean energy to light up their homes or businesses.
    Video

    Video Stunning Artworks Attract Record Crowds, Thanks to Social Media

    A new exhibit at the oldest art museum in America is shattering attendance records. Thousands of visitors are lining up to see nine giant works of art that have gotten a much-deserved shot of viral marketing. The 150-year-old Smithsonian American Art Museum has never had a response quite like this. VOA's Julie Taboh reports.
    Video

    Video Apprenticeships Put Americans on Path Back to Work

    Trying to get more people into the U.S. workforce, the Obama administration last year announced $175 million in grants towards apprenticeship programs. VOA White House correspondent Aru Pande went inside one training center outside of Washington that has gained national recognition for helping put people on the path to employment.
    Video

    Video New Material May Reduce Concussion Effects

    As the 2016 National Football League season reaches its summit at the Super Bowl this coming Sunday (2/7), scientists are trying to learn how to more effectively protect football players from dangerous and damaging concussions. Researchers at Cardiff and Cambridge Universities say their origami-based material may solve the problem. VOA’s George Putic reports.
    Video

    Video Saudi Arabian Women's Sports Chip Away at Stereotypes

    Saudi Arabian female athletes say that sports are on the front line of busting traditions that quash women’s voices, both locally and internationally. In their hometown of Jeddah, a group of basketball players say that by connecting sports to health issues, they are encouraging women and girls to get out of their homes and participate in public life. VOA’s Heather Murdock reports.
    Video

    Video A Year Later, Fortunes Mixed for Syrians Forging New Lives in Berlin

    In April of last year, VOA followed the progress of six young Syrian refugees -- four brothers and their two friends -- as they made their way from Libya to Italy by boat, and eventually to Germany. Reporter Henry Ridgwell caught up with the refugees again in Berlin, as they struggle to forge new lives amid the turmoil of Europe's refugee crisis.
    Video

    Video Zika Virus May be Hard to Stop

    With the Zika virus spreading rapidly, the World Health Organization Monday declared Zika a global health emergency. As Alberto Pimienta reports, for many governments and experts, the worst is yet to come.